Anavex Life Sciences Corp. (AVXL)
NASDAQ: AVXL · Real-Time Price · USD
8.72
-0.01 (-0.06%)
Feb 20, 2025, 11:54 AM EST - Market open

Anavex Life Sciences Income Statement

Millions USD. Fiscal year is Oct - Sep.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020 2019 - 2015
Period Ending
Dec '24 Sep '24 Sep '23 Sep '22 Sep '21 Sep '20 2019 - 2015
Selling, General & Admin
11.6211.1612.1613.149.156.09
Upgrade
Research & Development
41.3639.4240.8834.5228.3120.62
Upgrade
Operating Expenses
52.9850.5953.0447.6637.4626.71
Upgrade
Operating Income
-52.98-50.59-53.04-47.66-37.46-26.71
Upgrade
Interest & Investment Income
6.717.326.520.950.030.18
Upgrade
Currency Exchange Gain (Loss)
-0.30.19-0.04-0.9-0.270.13
Upgrade
Other Non Operating Income (Expenses)
0.090.08-0.04-0.050.15
Upgrade
EBT Excluding Unusual Items
-46.49-43-46.6-47.62-37.64-26.26
Upgrade
Other Unusual Items
---0.9---
Upgrade
Pretax Income
-46.49-43-47.5-47.62-37.64-26.26
Upgrade
Income Tax Expense
--0.010.360.270.02
Upgrade
Net Income
-46.49-43-47.51-47.98-37.91-26.28
Upgrade
Net Income to Common
-46.49-43-47.51-47.98-37.91-26.28
Upgrade
Shares Outstanding (Basic)
848380777058
Upgrade
Shares Outstanding (Diluted)
848380777058
Upgrade
Shares Change (YoY)
4.13%4.61%3.74%10.18%19.95%18.99%
Upgrade
EPS (Basic)
-0.55-0.52-0.60-0.62-0.54-0.45
Upgrade
EPS (Diluted)
-0.55-0.52-0.60-0.62-0.54-0.45
Upgrade
Free Cash Flow
-35.61-30.81-27.79-24.24-30.38-21.29
Upgrade
Free Cash Flow Per Share
-0.42-0.37-0.35-0.32-0.44-0.37
Upgrade
EBIT
-52.98-50.59-53.04-47.66-37.46-26.71
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.